Effect of magnesium on insulin resistance preventio
Phase 3
- Conditions
- Insulin resistance.Obesity, unspecified
- Registration Number
- IRCT2015110124756N2
- Lead Sponsor
- Hormozgan University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 76
Inclusion Criteria
BMI>28, general health in GI and cardiovascular system morbility, non diabetic, non pregnant, normotensive and no dietary restrictions or allergies, no history of food allergy or sensitivity to Mg supplements
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting Blood Sugar. Timepoint: Before intervention and every three months after intervention. Method of measurement: kit mg/dl.;Homa-IR. Timepoint: Before intervention and every three months after intervention. Method of measurement: HOMA–IR = FBG (mg/dl) × FPI (µu/ml) / 405).
- Secondary Outcome Measures
Name Time Method Insulin. Timepoint: Before intervention and every three months after intervention. Method of measurement: Kit µu/ml.;Lipid profiles. Timepoint: Before intervention and every three months after intervention. Method of measurement: Kit mg/dl.